{"title":"Corneal Complications Related to Dupilumab Use.","authors":"Jenna Tauber, D. Ritterband, Joann J Kang","doi":"10.1097/ICL.0000000000001093","DOIUrl":null,"url":null,"abstract":"OBJECTIVES\nThe aim of this report is to describe atypical corneal complications associated with dupilumab use.\n\n\nMETHODS\nThis is a series of four cases of adult patients with infiltrative or ulcerative keratitis secondary to dupilumab use.\n\n\nRESULTS\nAll four patients in this series were prescribed dupilumab for the treatment of atopic dermatitis and developed infiltrative or ulcerative corneal lesions. In all cases, corneal disease was successfully managed with immediate discontinuation of dupilumab and topical steroid treatment. In two cases, the patient also received antibiotic eye drops for infection precautions.\n\n\nCONCLUSIONS\nAlthough dupilumab is most commonly associated with conjunctivitis, physicians should be aware of potential severe corneal complications for early identification and intervention.","PeriodicalId":502139,"journal":{"name":"Eye & Contact Lens","volume":"58 19","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eye & Contact Lens","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ICL.0000000000001093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
OBJECTIVES
The aim of this report is to describe atypical corneal complications associated with dupilumab use.
METHODS
This is a series of four cases of adult patients with infiltrative or ulcerative keratitis secondary to dupilumab use.
RESULTS
All four patients in this series were prescribed dupilumab for the treatment of atopic dermatitis and developed infiltrative or ulcerative corneal lesions. In all cases, corneal disease was successfully managed with immediate discontinuation of dupilumab and topical steroid treatment. In two cases, the patient also received antibiotic eye drops for infection precautions.
CONCLUSIONS
Although dupilumab is most commonly associated with conjunctivitis, physicians should be aware of potential severe corneal complications for early identification and intervention.